Iskrov G - Search Results

1

Challenges in mapping European rare disease databases, relevant for ML-based screening technologies in terms of organizational, FAIR and legal principles: scoping review.

Raycheva R, Kostadinov K, Mitova E, Bogoeva N, Iskrov G, Stefanov G, Stefanov R. Raycheva R, et al. Among authors: iskrov g. Front Public Health. 2023 Sep 15;11:1214766. doi: 10.3389/fpubh.2023.1214766. eCollection 2023. Front Public Health. 2023. PMID: 37780450 Free PMC article.

2

General knowledge and awareness on rare diseases among general practitioners in Bulgaria.

Miteva Ts, Jordanova R, Iskrov G, Stefanov R. Miteva Ts, et al. Among authors: iskrov g. Georgian Med News. 2011 Apr;(193):16-9. Georgian Med News. 2011. PMID: 21617267

3

Challenges to orphan drugs access in Eastern Europe: the case of Bulgaria.

Iskrov G, Miteva-Katrandzhieva T, Stefanov R. Iskrov G, et al. Health Policy. 2012 Nov;108(1):10-8. doi: 10.1016/j.healthpol.2012.08.013. Epub 2012 Aug 29. Health Policy. 2012. PMID: 22939047

4

Insight into reimbursement decision-making criteria in Bulgaria: implications for orphan drugs.

Iskrov GG, Raycheva RD, Stefanov RS. Iskrov GG, et al. Folia Med (Plovdiv). 2013 Jul-Dec;55(3-4):80-6. doi: 10.2478/folmed-2013-0032. Folia Med (Plovdiv). 2013. PMID: 24712287

5

National registries of rare diseases in Europe: an overview of the current situation and experiences.

Taruscio D, Vittozzi L, Choquet R, Heimdal K, Iskrov G, Kodra Y, Landais P, Posada M, Stefanov R, Steinmueller C, Swinnen E, Van Oyen H. Taruscio D, et al. Among authors: iskrov g. Public Health Genomics. 2015;18(1):20-5. doi: 10.1159/000365897. Epub 2014 Sep 9. Public Health Genomics. 2015. PMID: 25228300

6

Prospects of risk-sharing agreements for innovative therapies in a context of deficit spending in bulgaria.

Iskrov G, Stefanov R. Iskrov G, et al. Front Public Health. 2015 Apr 22;3:64. doi: 10.3389/fpubh.2015.00064. eCollection 2015. Front Public Health. 2015. PMID: 25954739 Free PMC article. No abstract available.

7

Budget impact of rare diseases: proposal for a theoretical framework based on evidence from Bulgaria.

Iskrov G, Jessop E, Miteva-Katrandzhieva T, Stefanov R. Iskrov G, et al. Georgian Med News. 2015 May;(242):46-53. Georgian Med News. 2015. PMID: 26042447

8

Economic Burden And Health-Related Quality Of Life Of Patients With Cystic Fibrosis In Bulgaria.

Iskrov GG, Stefanov RS, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P; BURQOL-RD Research Network. Iskrov GG, et al. Folia Med (Plovdiv). 2015 Jan-Mar;57(1):56-64. doi: 10.1515/folmed-2015-0020. Folia Med (Plovdiv). 2015. PMID: 26431096

9

Criteria for Drug Reimbursement Decision-Making: An Emerging Public Health Challenge in Bulgaria.

Iskrov G, Stefanov R. Iskrov G, et al. Balkan Med J. 2016 Jan;33(1):27-35. doi: 10.5152/balkanmedj.2015.15185. Epub 2016 Jan 1. Balkan Med J. 2016. PMID: 26966615 Free PMC article.

10

Social/economic costs and health-related quality of life in patients with histiocytosis in Europe.

Iskrov G, Astigarraga I, Stefanov R, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Schieppati A, Taruscio D, Péntek M, von der Schulenburg JM, Kanavos P, Chevreul K, Persson U, Fattore G; BURQOL-RD Research Network. Iskrov G, et al. Eur J Health Econ. 2016 Apr;17 Suppl 1:67-78. doi: 10.1007/s10198-016-0790-5. Epub 2016 Apr 4. Eur J Health Econ. 2016. PMID: 27042831

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters